MedTrace Logo

Real-time Glaucoma Medication Adherence

NCT03194828 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-11-07

No results posted yet for this study

Summary

This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receive on-demand reminder messages, when necessary.

Conditions

Interventions

BEHAVIORAL

Medication reminder

Using the real-time data capture of the electronic device, an automated voice call or text message will be sent to active arm participants only when a missed dose is determined

BEHAVIORAL

Medication monitoring only

Patients will use an electronic medication monitoring device to record their actual medication use

Sponsors & Collaborators

  • Kali Care

    collaborator UNKNOWN

  • Barney's Pharmacy

    collaborator UNKNOWN

  • Creative Care Pharmacy

    collaborator UNKNOWN

  • Hutton Pharmacy

    collaborator UNKNOWN

  • Mustang Drug

    collaborator UNKNOWN

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Justin Gatwood, PhD · University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-08
Primary Completion
2018-07-15
Completion
2018-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03194828 on ClinicalTrials.gov